Come up with a name for your new list and we'll add to it:
Jennerex Biotherapeutics raised a round of funding on June 23, 2009. Investors include
Ontario Institute for Cancer Research.
Jennerex is a clinical-stage biopharmaceutical company focused on the development and commercialization of first-in-class, breakthrough targeted oncolytic products for cancer. The company's lead produ…